Notably, the fatty acid metabolism pathway was activated in the low-risk group, indicating that the imbalance between TXNRD1 mRNA expression and fatty acid metabolism regulation could promote poor prognosis in patients with HCC. The gene discussed is TXNRD1; the disease is hepatocellular carcinoma.